임상시험 이미징 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 성장률(CAGR) 9.3%로 22억 6,000만 달러에 달할 것으로 예측됩니다. 예측 기간의 성장 배경에는 만성질환 증가, 연구개발비 증가, 노인 인구 증가, 임상연구 증가, 위탁연구기관 증가 등이 있습니다. 예측 기간 동안 주요 동향으로는 이미징 양식을 강화하는 기술 발전, 역량 및 제품 제공을 확대하기 위한 시장 기업의 전략적 이니셔티브, 의약품 개발에서 이미징 기반 접근법 채택, 분자 이미징 및 AI 기반 분석의 발전, 제품 혁신 등이 있습니다. 제품 혁신 등을 꼽을 수 있습니다.
만성 질환의 유병률 증가는 향후 몇 년 동안 임상시험 이미징 시장의 성장을 가속할 것으로 예측됩니다. 만성질환은 지속적인 의학적 치료가 필요하고 일상 활동과 삶의 질에 큰 영향을 미치는 장기적인 질환입니다. 이러한 만성질환 증가는 대기오염, 화학물질, 독소 노출, 생활습관 변화, 유전적 영향 등의 요인에 기인합니다. 임상시험 이미징은 환자를 효율적으로 모니터링하고, 환자의 상태와 치료 효과에 대한 귀중한 통찰력을 제공하며, 환자의 순응도와 만족도를 향상시키는 데 중요한 역할을 하고 있습니다. 예를 들어, 미국 국립의학도서관인 국립생물공학정보센터(NCBI)는 2023년 1월, 2050년까지 최소 한 가지 이상의 만성질환을 앓고 있는 50세 이상 인구가 2020년 7,152만 명에서 1억 4,266만 명으로 99.5% 증가할 것으로 예측했습니다. 결과적으로 만성질환 유병률 증가는 임상시험 영상 시장의 성장을 견인하고 있습니다.
임상시험 이미징 시장의 주요 기업들은 개선된 솔루션을 제공하고 임상시험의 효율성을 높이기 위해 클라우드 기반 이미징 도구 개발에 주력하고 있습니다. 이러한 도구는 클라우드 컴퓨팅 기술을 활용하여 의료 이미지의 저장, 관리 및 분석을 수행합니다. 예를 들어, 2023년 3월 미국의 첨단 배전 시스템 제조업체인 클라리온(Clarion)은 혁신적인 클라우드 기반 이미지 뷰어 툴을 발표했습니다. 이 도구는 고해상도 이미지를 실시간으로 주문형으로 열람하고 조작할 수 있으며, 수작업이 필요 없는 읽기 품질에 대한 액세스를 제공합니다. 이 툴은 이미지 열람 프로세스를 간소화하고, 쉽고 안전하며 컴플라이언스를 준수하는 데이터 접근성을 보장하여 사용자가 임상시험 대상자에 대한 귀중한 통찰력을 얻을 수 있도록 지원합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 임상시험 이미징 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 임상시험 이미징 시장 : 성장률 분석
- 세계의 임상시험 이미징 시장 실적 : 규모와 성장, 2019-2024
- 세계의 임상시험 이미징 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 임상시험 이미징 전체 시장(TAM)
제6장 시장 세분화
- 세계의 임상시험 이미징 시장 : 제품 및 서비스별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 서비스
- 소프트웨어
- 세계의 임상시험 이미징 시장 : 모달리티별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 컴퓨터 단층촬영(CT)
- 자기공명영상(MRI)
- 심장 초음파 검사
- 핵의학
- 양전자 방출 단층촬영
- X선
- 초음파
- 광간섭 단층촬영
- 기타 모달리티
- 세계의 임상시험 이미징 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 종양학
- 신경학
- 심장병학
- 내분비학
- 피부과
- 혈액학
- 기타 용도
- 세계의 임상시험 이미징 시장 : 판매원별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 직접 판매
- 입찰 판매
- 세계의 임상시험 이미징 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 계약연구기관
- 제약 및 바이오테크놀러지 기업
- 의료기기 제조업체
- 학술기관 및 정부 연구기관
- 기타 최종사용자
- 세계의 임상시험 이미징 시장 : 서비스 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 진단을 위한 영상 진단 서비스
- 영상 취득 서비스
- 영상 분석 서비스
- 영상 관리 및 아카이브 서비스
- 세계의 임상시험 이미징 시장 : 소프트웨어 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 분석용 영상 소프트웨어
- 영상 처리 소프트웨어
- 방사선 정보 시스템(RIS)
- 영상 아카이브 및 통신 시스템(PACS(의료영상저장전송시스템))
제7장 지역별/국가별 분석
- 세계의 임상시험 이미징 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 임상시험 이미징 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 임상시험 이미징 시장 : 경쟁 구도
- 임상시험 이미징 시장 : 기업 개요
- Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
- Labcorp Drug Development Overview, Products and Services, Strategy and Financial Analysis
- Icon Plc Overview, Products and Services, Strategy and Financial Analysis
- PPD Inc. Overview, Products and Services, Strategy and Financial Analysis
- Syneos Health Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
- Charles River Laboratories
- Parexel International Corporation
- Clario
- Medpace Inc.
- Medidata Solution Inc.
- Biotelemetry Inc.
- WIRB-Copernicus Group
- ProScan Imaging LLC
- Invicro LLC
- Perspectum
- Radiant Sage LLC
- Worldcare Clinical LLC
- Intrinsic Imaging LLC
- Datatrak Inc.
- IXICO Plc
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 임상시험 이미징 시장(2029년) : 새로운 기회를 제공하는 국가
- 임상시험 이미징 시장(2029년) : 새로운 기회를 제공하는 부문
- 임상시험 이미징 시장(2029년) : 성장 전략
제36장 부록
LSH
Clinical trial imaging involves utilizing medical imaging techniques such as magnetic resonance imaging (MRI), computed tomography (CT) scans, and X-rays to capture detailed internal images of participants during clinical trials. These images play a vital role in monitoring disease progression, evaluating treatment efficacy, and ensuring patient safety, making it an essential component in assessing the biological impact of new therapies and interventions.
The primary products and services in clinical trial imaging include services and software. Clinical trial imaging services entail providing specialized imaging techniques and methodologies to support the research and development phases of clinical trials. Various modalities encompass computed tomography, magnetic resonance imaging, echocardiography, nuclear medicine, positron emission tomography, X-ray, ultrasound, optical coherence tomography, among others. These services cater to various applications such as oncology, neurology, cardiology, endocrinology, dermatology, hematology, and others, distributed through direct sales and tender sales. End-users include contract research organizations, pharmaceutical and biotechnology companies, medical device manufacturers, academic and government research institutes, among others.
The clinical trial imaging market research report is one of a series of new reports from The Business Research Company that provides clinical trial imaging market statistics, including clinical trial imaging industry global market size, regional shares, competitors with a clinical trial imaging market share, detailed clinical trial imaging market segments, market trends, and opportunities, and any further data you may need to thrive in the clinical trial imaging industry. This clinical trial imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The clinical trial imaging market size has grown strongly in recent years. It will grow from $1.44 billion in 2024 to $1.58 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increased sales and the distribution of clinical imaging software and services, increased risks of breast cancer, increased healthcare spending, rise in healthcare expenditure results in improved infrastructure, increased research and development spending by the pharmaceutical and biotechnological companies.
The clinical trial imaging market size is expected to see strong growth in the next few years. It will grow to $2.26 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to growing chronic diseases, rising research and development expenditures, an increasing geriatric population, a growing number of clinical studies, and an increasing number of contract research organizations. Major trends in the forecast period include technological advancements enhancing imaging modalities, strategic initiatives by market players to expand capabilities and offerings, adoption of imaging-based approaches in drug development, advancements in molecular imaging and AI-driven analysis, and product innovation.
The growing prevalence of chronic diseases is expected to drive the expansion of the clinical trial imaging market in the coming years. Chronic diseases are long-term conditions that require continuous medical attention and can significantly affect daily activities and quality of life. This increase in chronic diseases is attributed to factors such as exposure to air pollution, chemicals, and toxins, lifestyle changes, and genetic influences. Clinical trial imaging plays a crucial role in monitoring patients efficiently, providing valuable insights into their condition and the effects of treatments, which helps improve patient adherence and satisfaction. For example, the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, projected in January 2023 that by 2050, the number of individuals aged 50 and above with at least one chronic illness will rise by 99.5%, from 71.52 million in 2020 to 142.66 million. As a result, the increasing prevalence of chronic diseases is driving the growth of the clinical trial imaging market.
Major players in the clinical trial imaging market are focusing on developing cloud-based imaging tools to offer improved solutions and enhance clinical trial efficiency. These tools leverage cloud computing technology to store, manage, and analyze medical images. For instance, in March 2023, Clarion, a US-based manufacturer of advanced power distribution systems, introduced an innovative cloud-based image viewer tool. This tool enables real-time, on-demand viewing and manipulation of high-resolution images, providing read-quality access without the need for manual steps. It streamlines the image viewing process, ensuring easy, secure, and compliant data accessibility, empowering users to gain valuable insights into trial subjects.
In March 2023, Medica, a UAE-based medical company, acquired RadMD for an undisclosed sum. This strategic acquisition enables Medica to enter the clinical trials market, utilizing RadMD's expertise to enhance cost-efficiency and streamline drug and device development processes for pharmaceutical, biotech, and contract research organizations (CROs). RadMD, based in the US, specializes in offering clinical trial imaging solutions.
Major companies operating in the clinical trial imaging market are Koninklijke Philips N.V., Labcorp Drug Development, Icon Plc, PPD Inc., Syneos Health, Charles River Laboratories, Parexel International Corporation, Clario, Medpace Inc., Medidata Solution Inc., Biotelemetry Inc., WIRB-Copernicus Group, ProScan Imaging LLC, Invicro LLC, Perspectum, Radiant Sage LLC, Worldcare Clinical LLC, Intrinsic Imaging LLC, Datatrak Inc., IXICO Plc, Calyx Inc., Resonance Health Ltd., Anagram-ESIC SL
North America was the largest region in the clinical trial imaging market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the clinical trial imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The clinical trial imaging market consists of revenues earned by entities by providing services such as image protocol development, data management and integration, image processing, and analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical trial imaging market also includes sales of analysis tools, clinical trial management systems, and compliance tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Clinical Trial Imaging Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on clinical trial imaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for clinical trial imaging ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The clinical trial imaging market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product And Services: Services; Software
- 2) By Modality: Computed Tomography; Magnetic Resonance Imaging; Echocardiography; Nuclear Medicine; Positron Emission Tomography; X-Ray; Ultrasound; Optical Coherence Tomography; Other Modalities
- 3) By Application: Oncology; Neurology; Cardiology; Endocrinology; Dermatology; Hematology; Other Applications
- 4) By Distributer: Direct Sales; Tender Sales
- 5) By End User: Contract Research Organizations; Pharmaceutical And Biotechnology Companies; Medical Device Manufacturers; Academic And Government Research Institutes; Other End-Users
- Subsegments:
- 1) By Services: Imaging Services For Diagnostics; Image Acquisition Services; Image Analysis Services; Image Management And Archiving Services
- 2) By Software: Imaging Software For Analysis; Image Processing Software; Radiology Information Systems (RIS); Picture Archiving And Communication Systems (PACS)
- Companies Mentioned: Koninklijke Philips N.V.; Labcorp Drug Development; Icon Plc; PPD Inc.; Syneos Health
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Clinical Trial Imaging Market Characteristics
3. Clinical Trial Imaging Market Trends And Strategies
4. Clinical Trial Imaging Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Clinical Trial Imaging Growth Analysis And Strategic Analysis Framework
- 5.1. Global Clinical Trial Imaging PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Clinical Trial Imaging Market Growth Rate Analysis
- 5.4. Global Clinical Trial Imaging Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Clinical Trial Imaging Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Clinical Trial Imaging Total Addressable Market (TAM)
6. Clinical Trial Imaging Market Segmentation
- 6.1. Global Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Services
- Software
- 6.2. Global Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Computed Tomography
- Magnetic Resonance Imaging
- Echocardiography
- Nuclear Medicine
- Positron Emission Tomography
- X-Ray
- Ultrasound
- Optical Coherence Tomography
- Other Modalities
- 6.3. Global Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oncology
- Neurology
- Cardiology
- Endocrinology
- Dermatology
- Hematology
- Other Applications
- 6.4. Global Clinical Trial Imaging Market, Segmentation By Distributer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Direct Sales
- Tender Sales
- 6.5. Global Clinical Trial Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Contract Research Organizations
- Pharmaceutical And Biotechnology Companies
- Medical Device Manufacturers
- Academic And Government Research Institutes
- Other End-Users
- 6.6. Global Clinical Trial Imaging Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Imaging Services For Diagnostics
- Image Acquisition Services
- Image Analysis Services
- Image Management And Archiving Services
- 6.7. Global Clinical Trial Imaging Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Imaging Software For Analysis
- Image Processing Software
- Radiology Information Systems (RIS)
- Picture Archiving And Communication Systems (PACS)
7. Clinical Trial Imaging Market Regional And Country Analysis
- 7.1. Global Clinical Trial Imaging Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Clinical Trial Imaging Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Clinical Trial Imaging Market
- 8.1. Asia-Pacific Clinical Trial Imaging Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Clinical Trial Imaging Market
- 9.1. China Clinical Trial Imaging Market Overview
- 9.2. China Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Clinical Trial Imaging Market
- 10.1. India Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Clinical Trial Imaging Market
- 11.1. Japan Clinical Trial Imaging Market Overview
- 11.2. Japan Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Clinical Trial Imaging Market
- 12.1. Australia Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Clinical Trial Imaging Market
- 13.1. Indonesia Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Clinical Trial Imaging Market
- 14.1. South Korea Clinical Trial Imaging Market Overview
- 14.2. South Korea Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Clinical Trial Imaging Market
- 15.1. Western Europe Clinical Trial Imaging Market Overview
- 15.2. Western Europe Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Clinical Trial Imaging Market
- 16.1. UK Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Clinical Trial Imaging Market
- 17.1. Germany Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Clinical Trial Imaging Market
- 18.1. France Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Clinical Trial Imaging Market
- 19.1. Italy Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Clinical Trial Imaging Market
- 20.1. Spain Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Clinical Trial Imaging Market
- 21.1. Eastern Europe Clinical Trial Imaging Market Overview
- 21.2. Eastern Europe Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Clinical Trial Imaging Market
- 22.1. Russia Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Clinical Trial Imaging Market
- 23.1. North America Clinical Trial Imaging Market Overview
- 23.2. North America Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Clinical Trial Imaging Market
- 24.1. USA Clinical Trial Imaging Market Overview
- 24.2. USA Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Clinical Trial Imaging Market
- 25.1. Canada Clinical Trial Imaging Market Overview
- 25.2. Canada Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Clinical Trial Imaging Market
- 26.1. South America Clinical Trial Imaging Market Overview
- 26.2. South America Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Clinical Trial Imaging Market
- 27.1. Brazil Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Clinical Trial Imaging Market
- 28.1. Middle East Clinical Trial Imaging Market Overview
- 28.2. Middle East Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Clinical Trial Imaging Market
- 29.1. Africa Clinical Trial Imaging Market Overview
- 29.2. Africa Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Clinical Trial Imaging Market Competitive Landscape And Company Profiles
- 30.1. Clinical Trial Imaging Market Competitive Landscape
- 30.2. Clinical Trial Imaging Market Company Profiles
- 30.2.1. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Labcorp Drug Development Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Icon Plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. PPD Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Syneos Health Overview, Products and Services, Strategy and Financial Analysis
31. Clinical Trial Imaging Market Other Major And Innovative Companies
- 31.1. Charles River Laboratories
- 31.2. Parexel International Corporation
- 31.3. Clario
- 31.4. Medpace Inc.
- 31.5. Medidata Solution Inc.
- 31.6. Biotelemetry Inc.
- 31.7. WIRB-Copernicus Group
- 31.8. ProScan Imaging LLC
- 31.9. Invicro LLC
- 31.10. Perspectum
- 31.11. Radiant Sage LLC
- 31.12. Worldcare Clinical LLC
- 31.13. Intrinsic Imaging LLC
- 31.14. Datatrak Inc.
- 31.15. IXICO Plc
32. Global Clinical Trial Imaging Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Clinical Trial Imaging Market
34. Recent Developments In The Clinical Trial Imaging Market
35. Clinical Trial Imaging Market High Potential Countries, Segments and Strategies
- 35.1 Clinical Trial Imaging Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Clinical Trial Imaging Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Clinical Trial Imaging Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
